Riskpilot← Back to searchSign inGet full accessSINACO AB
ABActiveOrg 5569704041StockholmGeneral medical practice activities · NACE 8621Est. 20141 employees
Revenue 2025
SEK 428K
-58% vs 2024
EBITDA margin
-63.0%
-177% vs 2024
Equity ratio
63.3%
Financial strength
Net profit 2025
SEK -52K
-101% vs 2024
| Revenue | SEK 428K | -58% |
| EBITDA | SEK -269K | -177% |
| Net profit | SEK -52K | -101% |
| Total assets | SEK 5,2M | -23% |
| Equity | SEK 3,3M | -38% |
| Employees | 1 | — |
Legal name
SINACO AB
Org number
5569704041
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 maj 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjukvård, import och export av medicinska produkter såsom läkemedel och instrument, kulturell verksamhet såsom produktion av musik och turismverksamhet jämte därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 224 | 870 | 906 | 1 020 | 428 |
| Staff expenses | — | — | — | — | −8 |
| EBITDA | 992 | 682 | 746 | 349 | −269 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −118 |
| EBIT | 992 | 682 | 746 | 349 | −388 |
| Net financials | −113 | −27 | −24 | 4 986 | −24 |
| Profit before tax | 897 | 492 | 536 | 5 334 | −52 |
| Tax | −205 | −107 | −115 | −73 | — |
| Net profit | 692 | 385 | 421 | 5 261 | −52 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 713 | 1 879 | 1 790 | 6 747 | 5 197 |
| Equity | 763 | 1 148 | 979 | 5 340 | 3 288 |
| Long-term debt | 274 | 46 | 73 | 0 | 559 |
| Short-term debt | 676 | 511 | 379 | 1 047 | 1 350 |
| Total debt | 950 | 557 | 452 | 1 047 | 1 909 |
EBITDA margin
-63.0%
This company
15.8%
Market median
-499% vs market
20212025
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20212025
Return on equity
-1.6%
This company
18.4%
Market median
-109% vs market
20212025
Net profit margin
-12.2%
This company
8.1%
Market median
-251% vs market
20212025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH | Audit | 2022 |
IM Auditor Substitute | Auditor Substitute | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SINACO AB 
Vårdval Sigtuna ABBoard members of SINACO AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Håkan Daniel Fjelner | Audit | 0 companies |
| Ivan Mikael Larsson | Auditor Substitute | 0 companies |
| Sepideh Zabihi Nejad | Deputy Board Member | 0 companies |
| Shahab Farnamfar | Board of Directors | 0 companies |